The race event of the National Center for Tumor Diseases (NCT) Heidelberg took place for the 5th time last Friday, 8 July 2016. Tousands of participants including patients and their families, physichians, scientists and friends of the NCT run “to opose cancer with a positive note” participated this year. An EMBL team supports this initiative every year.
See more (in German only)
From the left to the right: Annika Gable, Mike Smith, Britta Velten, Karsten Bach, Junyan Lu, Nils Kurzawa and Alejandro Reyes from the Huber Group.
Abstract: Hypothesis weighting improves the power of large-scale multiple testing. We describe independent hypothesis weighting (IHW), a method that assigns weights using covariates independent of the P-values under the null hypothesis but informative of each test’s power or prior probability of the null hypothesis: www.bioconductor.org/packages/IHW. IHW increases power while controlling the false discovery rate and is a practical approach to discovering associations in genomics, high-throughput biology and other large data sets.
Arne has a PhD degree from the Radboud University (Nijmegen, The Netherlands). His previous research in the laboratory of Prof. Michiel Vermeulen focused on the identification and quantification of protein-protein and DNA-protein interactions using quantitative proteomics. As a EIPOD postdoctoral fellow at EMBL, he is studying the systems-wide effects of drug treatment in collaboration with Cellzome and the Steinmetz group.
At EMBL, Nikos works on data-driven hypothesis weighting for false discovery rate control as part of his Bachelor’s and Master’s thesis, which he will finish in August 2016. In September, he will join Stanford’s Statistics department to start his PhD!
CSAMA 2016 (14th edition)
Statistics and Computing in Genome Data Science
Bressanone-Brixen, Italy (South Tyrol Alps)
July 10-15, 2016
- Simon Anders, Institute for Molecular Medicine, Helsinki
- Jennifer Bryan, University of British Columbia, Vancouver
- Vincent J. Carey, Channing Laboratory, Harvard Medical School
- Wolfgang Huber, European Molecular Biology Laboratory (EMBL), Heidelberg
- Michael Love, Dana Farber Cancer Institute and the Harvard School of Public Health
- Martin Morgan, Roswell Park Cancer Institute, Buffalo, New York.
- Charlotte Soneson, University of Zurich
- Levi Waldron, CUNY School of Public Health at Hunter College, New York
- Simone Bell, EMBL, Heidelberg
- Alejandro Reyes, EMBL, Heidelberg
- Mike L. Smith, EMBL, Heidelberg
The one-week intensive course Statistics and Computing in Genome Data Science teaches statistical and computational analysis of multi-omics studies in biology and biomedicine. It covers the underlying theory and state of the art (the morning lectures), and practical hands-on exercises based on the R / Bioconductor environment (the afternoon labs). The course covers the primary analysis of high-throughput sequencing based assays in functional genomics and integrative methods including efficiently operating with genomic intervals, statistical testing, linear models, machine learning, bioinformatic annotation and visualization. At the end of the course, you should be able to run analysis workflows on your own (multi-)omic data, adapt and combine different tools, and make informed and scientifically sound choices about analysis strategies.
- Introduction to Bioconductor
- Elements of statistics: hypothesis testing, multiple testing, regression, regularization, clustering and classification (machine learning), visualization
- Computing with sequences and genomic intervals
- Integrating multiple layers of ‘omic data
- Working with annotation – genes, genomic features and variants
- RNA-Seq data analysis and differential expression
- Single-cell RNA-Seq
- Proteomics primers
- Interactive displays with Shiny
The course consists of
- morning lectures: 20 x 45 minutes: Monday to Friday 8:30h – 12:00h
- 4 practical computer tutorials in the afternoons (14:00h – 17:00h) on Monday, Tuesday, Thursday and Friday
The registration for CSAMA 2016 closed on June 15th 2016
Visit the course’s website at: http://www.huber.embl.de/csama
Sophie studied Molecular Biotechnology at the University of Heidelberg. She joined the Huber Group in Spring 2014 as student research assistant and worked on genomic biomarkers of drug sensitivity in primary blood cancer cells. For her PhD thesis, Sophie is now joining the group of Sascha Dietrich at NCT Heidelberg, where she will work on the SYMPATHY project, an integrated system medicine approach to personalized and targeted therapy in leukaemia and lymphoma. This multidisciplinary project is intended to have direct clinical impact on patient care in blood cancers.
At EMBL, Jackie worked on her Master thesis, which she successfully finished in October 2015 with an excellent mark! In September 2016, she will start to work on her PhD thesis at the Centre for Genomic Regulation in Barcelona. Jackie was awarded the La Caixa Fellowship for the coming four years.
Karsten Bach has a B.Sc. in Biology from the University of Bonn. He joined the Huber group in March 2016. At EMBL, he is finishing up his M.Sc. in Molecular Biotechnology and working on quantitative proteomics together with Dorothee Childs and Nikos Ignatiadis.
The second consortium meeting of the SOUND project, which is led by Wolfgang Huber, was hosted by our colleagues from IDMEC Lisbon. Principal investigators, postdocs and PhD students attended the meeting and presented recent results and progress in the work packages. All partners are well on track with their project aims and the atmosphere of sharing research developments was quite enthusiastic. Junyan Lu held a talk on “Mechanistic study of drug response using ex-vivo drug testing and multi-omics technology“ and Małgorzata Oleś provided a presentation on “Modulators of drug response identified by multivariate lasso regression”. Wolfgang Huber gave a lecture on “Data driven hypothesis weighting and false discovery rates”.
Photos from Lisbon by Junyan Lu.
Dorothee Childs presented her work at the EMBL-Wellcome Genome Campus Conference “Target Validation using Genomics and Informatics 2015”, which took place from 8th to 10th December 2015 in Cambridge.
More than 200 people attended this ground-breaking conference. Dorothee gave a talk on “Screening for drug targets in intact cells by thermal proteome profiling”, a project in which she is involved as part of a collaboration between EMBL Heidelberg and GSK’s SME Cellzome, which is also based in Heidelberg.”